Skip to main content

Table 4 Disease-free survival by groups A, B, C and D

From: Adjuvant chemotherapy is an additional option for locally advanced gastric cancer after radical gastrectomy with D2 lymphadenectomy: a retrospective control study

Adjuvant Chemotherapy cycles Not received (A) 7–8 or 10–12 cycles (B) 4–6 or 6–9 cycles (C) ≤3 or 5 cycles (D)
P P P P
Not received (A)   0.003 0.018 0.838
7–8 or 10–12 cycles (B) 0.003   0.716 0.003
4–6 or 6–9 cycles (C) 0.018 0.716   0.015
≤3 or 5 cycles (D) 0.838 0.003 0.015  
  1. Note: According to the Bonferroni method, α was adjusted by dividing 0.05 by 6, P < 0.008, statistically significant